×
We recently upgraded the website!  If you run into any issues, please Contact Us.  We'd also love to hear your feedback!  Enjoy exploring the new site!

Sponsored Webcast: How AI will Power the Future of Proofreading in Pharma (On Demand)

Member: $0 | Nonmember: $50
Learn about the advantages of incorporating artificial intelligence & automation in proofreading processes, leading to streamlined workflows, reduced errors, and faster time-to-market for life-saving drugs.

In the fast-paced and highly competitive world of pharmaceuticals, precision is paramount to achieving success. However, in recent times, the need for accuracy has been accompanied by an equally pressing demand for speed. The presentation will delve into the advantages of incorporating artificial intelligence and automation in proofreading processes, leading to streamlined workflows, reduced errors, and faster time-to-market for life-saving drugs.

Registration Fees & Deadlines

Member $0 | Nonmember $50

Learning Objectives

  • How AI and automation will help regulatory teams in predicting errors that matter and how to automatically discard differences that don't

  • How "smart proofreading" will address the challenges professionals face in ensuring accuracy while grappling with tight timelines, complex data, and a myriad of regulatory requirements

  • How GlobalVision inspection solutions leverage AI technology, and support and streamline our customer’s day-to-day responsibilities

  • How AI technology will continue to support GlobalVision’s future technology roadmap

Who Should Attend?

Regulatory or QA professionals at pharmaceutical companies

Audience Learning Level

Intermediate: Content is designed based upon the assumption that individuals have basic knowledge of the topic(s) and/or demonstrated competence related to the topic(s). Higher-level concepts are introduced during lectures; exercises requiring synthesis and/or application of concepts are incorporated into the activity.

Speakers

Arpad Lehoczki

Arpad Lehoczki
GlobalVision, Director of LifeScience Strategy